Loading clinical trials...
Loading clinical trials...
Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System: A Pivotal and Continued Access Study
The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).
This study will evaluate the safety and effectiveness of the Nellix System among a wide range of physicians and in consecutively enrolled subjects to assess outcomes generalizability. Following appropriate government and ethics committee/IRB approval the Nellix® EndoVascular Sealing System will be implanted into eligible patients who are adequately informed and have consented to join the study. Enrolled patients will undergo a high resolution, contrast-enhanced computed tomography angiography (CT) scan of the relevant aortic and aortoiliac vasculature within three months of the scheduled procedure and at specified follow-up intervals post-implantation. Follow-up visits will occur at 30 days, 6 months, and annually to 5 years to assess aneurysm morphology, the status of the implanted devices, and relevant laboratory test results.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Tucson Medical Center
Tucson, Arizona, United States
VA San Diego
San Diego, California, United States
Yale University
New Haven, Connecticut, United States
Christiana Care Hospital
Newark, Delaware, United States
MedStar Health Research Institute
Washington D.C., District of Columbia, United States
Baptist Hospital of Miami
Miami, Florida, United States
Sacred Heart
Pensacola, Florida, United States
St. Vincent Heart Center of Indiana
Indianapolis, Indiana, United States
Maine Medical Center
Portland, Maine, United States
St. Elizabeth's Medical Center
Brighton, Massachusetts, United States
Start Date
December 1, 2013
Primary Completion Date
June 1, 2016
Completion Date
December 1, 2022
Last Updated
February 28, 2025
333
ACTUAL participants
Nellix System
DEVICE
Lead Sponsor
Endologix
NCT06586021
NCT04592991
NCT03231397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions